Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Zotiraciclib citrate by Beijing zhikangbo Medical Oncology Research for High-Grade Glioma: Likelihood of Approval
Zotiraciclib citrate is under clinical development by Beijing zhikangbo Medical Oncology Research and currently in Phase II for High-Grade Glioma....
Data Insights
Zotiraciclib citrate by Beijing zhikangbo Medical Oncology Research for Glioblastoma Multiforme (GBM): Likelihood of Approval
Zotiraciclib citrate is under clinical development by Beijing zhikangbo Medical Oncology Research and currently in Phase II for Glioblastoma Multiforme...